...
首页> 外文期刊>International journal of rheumatology >Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study
【24h】

Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study

机译:风湿性多肌痛和巨细胞动脉炎患者对预防性骨质疏松症药物依从性的水平:跨领域研究

获取原文
           

摘要

Objective. To estimate level of adherence to oral calcium and vitamin D supplementation as well as bisphosphonate amongst patients with PMR and GCA treated with glucocorticoids.Method. A total of 138 patients with the diagnosis of PMR and/or GCA registered in our department in December 2013. In this cross-sectional study we interviewed all the patients to measure level of adherence to calcium and vitamin D, as well as bisphosphonates.Results. Out of the 118 included patients, 88.9% of them were adherent to their prescription. Only 2 patients (1.7%) did not take calcium and vitamin D at all and 10 patients (8.5%) took their medication infrequently, 9 and 1 out of 10 patients took the medication 50–100% of the time and less than 50% of the prescribed dose, respectively. Sixty-one patients received additional treatment with bisphosphonate and 96.6% were adherent to this therapy. The remaining 3.4% of the patients did not take the medication at all. Forgetfulness, adverse side effects, and lack of understanding of treatment benefits were the most significant causes for nonadherence to calcium and vitamin D.Conclusions. Contrary to what we expected this study found that adherence to osteoporosis preventive medication in patients with PMR and GCA was high.
机译:目的。为了评估接受糖皮质激素治疗的PMR和GCA患者中口服钙和维生素D补充剂以及双膦酸盐的依从性水平。 2013年12月,共有138名诊断为PMR和/或GCA的患者在我科登记。在本横断面研究中,我们采访了所有患者,以测量其对钙和维生素D以及双膦酸盐的依从性水平。 。在118名患者中,有88.9%遵守处方。只有2例患者(1.7%)完全没有服用钙和维生素D,10例患者(8.5%)很少用药,十分之九和1的患者在50-100%的时间内服药,而少于50%分别按规定剂量服用。六十一例患者接受了额外的双膦酸盐治疗,其中96.6%的患者坚持这种治疗。其余3.4%的患者根本没有服用药物。健忘,不利的副作用以及对治疗益处的缺乏了解是不坚持钙和维生素D的最重要原因。与我们预期的相反,本研究发现PMR和GCA患者对预防骨质疏松药物的依从性很高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号